Dixon Hubard Feinour & Brown’s Sanofi SNY Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,375	Closed	-$319K	–	314
2021 Q4	$319K	Buy	+6,375	New	+$315K	0.03%	257
2015 Q4	–	Sell	-17,971	Closed	-$853K	–	183
2015 Q3	$853K	Sell	17,971 -750	-4%	-$38.2K	0.31%	80
2015 Q2	$927K	Sell	18,721 -3,034	-14%	-$154K	0.29%	88
2015 Q1	$1.08M	Sell	21,755 -133	-0.6%	-$6.36K	0.32%	81
2014 Q4	$998K	Sell	21,888 -133	-0.6%	-$6.45K	0.31%	84
2014 Q3	$1.24M	Sell	22,021 -134	-0.6%	-$7.2K	0.41%	65
2014 Q2	$1.18M	Hold	22,155	–	–	0.38%	68
2014 Q1	$1.16M	Sell	22,155 -200	-0.9%	-$10.1K	0.4%	65
2013 Q4	$1.2M	Sell	22,355 -4,100	-15%	-$212K	0.44%	59
2013 Q3	$1.34M	Sell	26,455 -50	-0.2%	-$2.54K	0.57%	54
2013 Q2	$1.36M	Buy	+26,505	New	+$1.41M	0.61%	51

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Dixon Hubard Feinour & Brown's SNY Position: Q1 2022 in Review

Dixon Hubard Feinour & Brown sold out of Sanofi (SNY) in Q1 2022, closing a stake of 6,375 shares — an estimated $319K sold.

Dixon Hubard Feinour & Brown first reported a position in SNY in Q2 2013 and held it in 11 quarters. The position peaked at $1.36M in Q2 2013. 623 funds tracked by Wall St. Rank hold SNY as of Q1 2022.

Dixon Hubard Feinour & Brown reported no remaining Sanofi position as of Q1 2022 after selling out during the quarter.
Dixon Hubard Feinour & Brown sold 6,375 Sanofi shares in Q1 2022, an estimated $319K.
Dixon Hubard Feinour & Brown first reported a position in Sanofi in Q2 2013 and held it in 11 quarters.
Dixon Hubard Feinour & Brown's Sanofi position peaked at $1.36M in Q2 2013.
623 funds tracked by Wall St. Rank held Sanofi as of Q1 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q1 2022, filed 9 May 2022.